高清不卡日本v二区在线,天天综合网天天综合,激情丁香五月天婷婷水蜜桃视频,91精品免费久久久久久久久,手机看片久久久久久久久,日日夜夜嫩草,日本不卡 在线视频,欧美亚洲日韩,高潮歹无毛免费观看视频,天天综合网7799日日夜夜永,欧美日本国产日韩激情视频 ,久久久无码精品亚洲日韩蜜桃,日夜夜天天人人综合网,91蜜桃长长久久,国产精品精品一区在线发布,一级a毛片免费观看久久精品

What is the registration process for in vitro diagnostics in the United States?
Category：企業(yè)動(dòng)態(tài) Date：2025-01-10 17:29:19 Author: Source:
The registration process for in vitro diagnostics (IVDs) in the United States involves several steps regulated by the U.S. Food and Drug Administration (FDA). Below is an overview of the process:

The registration process for in vitro diagnostics (IVDs) in the United States involves several steps regulated by the U.S. Food and Drug Administration (FDA). Below is an overview of the process:

  1. Determine the Classification: IVDs are classified into three categories (Class I, Class II, or Class III) based on risk. The classification determines the regulatory requirements, including the level of oversight needed.

  2. 底部圖3(1).png

  3. Pre-market Notification (510(k)) or Pre-market Approval (PMA):

    • 510(k) Submission: Most Class II devices (and some Class I devices) require a 510(k) pre-market notification. This involves submitting evidence that the device is substantially equivalent to an already legally marketed device.
    • PMA: Class III devices (high-risk IVDs) require pre-market approval. This involves submitting clinical trial data and other information to prove the device’s safety and effectiveness.

  4. Establish a Quality Management System (QMS): Manufacturers must comply with the FDA’s Quality System Regulation (QSR) (21 CFR 820), ensuring that the device is manufactured in accordance with strict quality control standards.

  5. Labeling Requirements: IVDs must comply with the FDA’s labeling regulations, which include providing clear and accurate instructions for use, as well as warnings and other important information.

  6. Registration and Listing:

    • Manufacturers must register their establishment with the FDA and list their IVD product(s) with the FDA.
    • This process involves submitting the device’s details, including its intended use and classification.

  7. Post-Market Surveillance: After the device is marketed, manufacturers must monitor and report any adverse events or product defects to the FDA. In some cases, post-market clinical studies or additional regulatory approvals may be required.

Each step may vary depending on the risk classification of the device, and additional requirements may apply for certain types of IVDs (e.g., laboratory-developed tests or home-use tests). It's important to consult with the FDA or a regulatory expert to ensure compliance with all applicable regulations.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn